STOCK TITAN

Tao Synergies Inc. 10-Q Filings

TAOX NASDAQ

Every 10-Q that Tao Synergies Inc. (TAOX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow TAOX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TAOX filings page.

Rhea-AI Summary

TAO Synergies Inc. reports a crypto-focused balance sheet and ongoing losses for the quarter ended June 30, 2026. Total assets were $21.1 million, including $16.8 million of TAO digital assets and $2.4 million of cash and cash equivalents; stockholders’ equity fell to $12.7 million from $21.1 million at December 31, 2025.

Revenue now comes solely from TAO staking, reaching $88,626 for the quarter and $477,400 for six months. The company recorded a quarterly net loss of $9.3 million, driven largely by an $8.4 million unrealized loss on digital assets and preferred stock dividends and deemed dividends, bringing the six‑month net loss to $5.0 million and the net loss attributable to common stockholders to $9.6 million.

The company has adopted a long‑only TAO treasury strategy, allocating between 75% and 100% of excess cash to TAO; as of June 30, 2026, about 87.7% of treasury holdings were invested in TAO, with 83,306 tokens held and $11.3 million in cumulative unrealized losses. Management expects current cash and TAO value to cover at least 12 months of operations but states that additional capital will be needed to continue pursuing this strategy, noting potential dilution from equity financing and risks if capital is not obtained.

Rhea-AI Summary

TAO Synergies Inc. reported a sharp swing to profitability for the quarter ended March 31, 2026, driven by gains on its cryptocurrency holdings. The company generated $388,774 in revenue from TAO staking while posting an operating loss of $1.3 million, mainly from $1.7 million of general and administrative costs and modest research and development spending.

Net income reached $4.25 million, up from $0.39 million a year earlier, largely due to a $6.84 million unrealized gain on digital assets and $0.35 million of gains on Yuma partnership investments, partially offset by a $1.65 million loss from changes in derivative liabilities. Cash and cash equivalents were $3.6 million and digital assets were $25.2 million, giving total assets of $31.0 million.

The company has adopted a concentrated, long-only cryptocurrency treasury strategy focused on TAO, with about 87.3% of treasury holdings in TAO as of March 31, 2026 and 82,210 tokens held. Management believes current cash and TAO market value can fund operations for at least 12 months while it continues accumulating TAO and evaluates paths forward for its Bryostatin-1 drug program, but it also acknowledges that additional capital will be needed to support its crypto treasury strategy.

Rhea-AI Summary

TAO Synergies Inc. (TAOX) filed its Q3 2025 10-Q, highlighting a pivot to a TAO-focused crypto treasury strategy and initial staking revenue. The company reported Q3 staking revenue of $203,371 and a Q3 net loss of $3,923,247. For the nine months, staking revenue totaled $207,333 with a net loss of $21,054,156, driven by operating expenses and significant non-cash fair value changes in warrant and derivative liabilities.

On the balance sheet, cash and equivalents were $1,445,427, digital assets were $15,381,039 (50,363.26 TAO at period-end fair value), and total assets were $18,358,987. Total liabilities were $1,690,046, including a warrant liability of $646,000 and a derivative liability of $2,000. Stockholders’ equity was $16,065,144. The company issued and converted preferred securities during the year and recorded $2,014,783 from investor warrant exercises and $4,924,000 net proceeds from Series D preferred, while investing $17,570,203 to acquire TAO tokens. As of November 11, 2025, common shares outstanding were 7,128,912. Management continues to stake TAO via BitGo-supported validators (tao5 and Yuma) and launched The TAO Daily media platform to support its ecosystem focus.

Rhea-AI Summary

TAO Synergies Inc. (TAOX) disclosed capital structure changes, contractual obligations, related-party compensation and valuation of recent securities in this Form 10-Q. At June 30, 2025 the company reported 2,504,911 shares of common stock outstanding (1,357,165 at 12/31/2024). Two preferred series carry liquidation preferences of $223,500 (plus $17,665 accrued dividends) and $5,500,000 (plus $16,806 accrued dividends). The company held cash and equivalents including approximately $13.5 million in a money market fund and U.S. Treasury bills and approximately $4.5 million in cryptocurrency (not FDIC insured).

The filing details license and royalty arrangements (milestone caps of up to $3.7M and other potential payments to Stanford and Mt. Sinai), related-party consulting and executive compensation arrangements including a new Executive Chairman agreement with enhanced severance and equity incentives, and recent preferred and warrant financings (Series C and Series D) with conversion features, full-ratchet price protections and installment redemptions beginning Sept 30, 2025. Fair values for warrants and derivatives were estimated using Black-Scholes with volatilities generally above 100% and material warrant fair values disclosed (e.g., Series C warrants ~$8.6M).